Trials / Completed
CompletedNCT04285788
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogeneic Hematopoietic Cell Transplant Recipients: AdVance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 216 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- All
- Age
- 0 Months – 90 Years
- Healthy volunteers
- Not accepted
Summary
To depict the incidence, outcomes and standards of care (SoC) of adenovirus (AdV) infections and associated practice patterns in allogeneic hematopoietic cell transplant recipients. It is expected that participating centers will be in the United Kingdom, France, Spain, Germany, and Italy.
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-09-01
- Completion
- 2017-01-01
- First posted
- 2020-02-26
- Last updated
- 2022-03-25
Source: ClinicalTrials.gov record NCT04285788. Inclusion in this directory is not an endorsement.